Considering that Ang II-driven HTN manifests differently in females, that antihypertensive drug efficacy varies across racial and ethnic groups, and that intestinal barrier function declines with age, addressing these gaps is essential to improve generalizability and translational relevance. The gene discussed is AGT; the disease is hypertensive disorder.